Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
about
Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantomApplication and Dosimetric Requirements for Gallium-68-labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine TumorsTheranostic Imaging of Yttrium-90Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences.Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy.Optimal design of anger camera for bremsstrahlung imaging: monte carlo evaluation.The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y.Quantitative and qualitative assessment of Yttrium-90 PET/CT imaging.Positron Emission Tomography (PET) in OncologyPET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment EfficacyCherenkov luminescence measurements with digital silicon photomultipliers: a feasibility study.Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncologyThe joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumoursA review of 3D image-based dosimetry, technical considerations and emerging perspectives in (90)Y microsphere therapy.Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reportingRadiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and TherapyYttrium-labelled peptides for therapy of NET.Lutetium-labelled peptides for therapy of neuroendocrine tumours.Matching chelators to radiometals for radiopharmaceuticals.Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres.Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres.Inter-comparison of quantitative imaging of lutetium-177 (Lu) in European hospitals
P2860
Q22001026-26EB71D2-73AF-4DE3-A2FB-7993DA1DE797Q26783272-88381022-F130-4905-9BA0-AC40D3B06886Q28083044-A527716D-C5A3-4F69-ACD1-576A0FEEE72BQ30399809-5C89460B-8B0D-4863-BB8C-2B8F486594C0Q30524018-ADADD072-F366-4410-9291-4B6E9A27DD9DQ33751252-3EE48BD3-D13B-4406-A925-557DB9C1A317Q33851546-4FB5EDA7-636B-4F32-AC60-E5C600ED69BFQ34450157-C34D6FE9-E24E-4E10-B46D-F3C9BDB5BA2CQ34774840-4B291135-64C4-49DC-B5C6-988ADF9B28B5Q36194191-3DE66BCC-120B-49B0-B6CD-935037236D59Q36285018-E3C4B09E-833C-477C-BE4B-DFBC1A681678Q36339722-D52647F3-5A75-46F2-87BE-452A45227334Q36755905-1E1F15AC-7489-46B2-B9F5-6553F1496278Q36899620-3D133271-57A8-4F7D-AF2D-3C1D079EA440Q37053297-21AAC93A-1297-46E6-932D-6E5806D9A288Q37689802-7AA2786E-ABB8-4333-95BC-11385F8DDC41Q37990401-CC77F760-6B95-46BA-87F2-2506D593B650Q37990411-6D1C8CC7-1533-49F3-A80F-65F325BDBB53Q38156660-76877943-54D8-4936-8677-E68FED9A1061Q38534001-FA5AC1D3-1ECF-4A25-9A3C-62F5C7BA5A71Q38612027-6931E9FB-AF3A-451D-86D5-AD45CF2165D6Q39289085-602D5106-6E90-4871-B870-B8E7FE666CDDQ41485304-3CC940A1-8620-4369-A871-2F50A5B53BD5Q47826137-DA5A9247-1EEB-40C1-9A25-3E5590BCE083Q58803949-ED39670B-4DA0-48B6-8C6A-3902D1199F95
P2860
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@en
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@nl
type
label
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@en
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@nl
prefLabel
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@en
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@nl
P2093
P2860
P1476
Dosimetry of yttrium-labelled ...... l therapy: 86Y or 90Y imaging?
@en
P2093
Eric P Krenning
Francois Jamar
Mark W Konijnenberg
Renaud Lhommel
Roelf Valkema
Stanislas Pauwels
Stephan Walrand
P2860
P2888
P304
P356
10.1007/S00259-011-1771-7
P478
38 Suppl 1
P50
P577
2011-03-11T00:00:00Z